v3.25.2
Revenue - Disclosure of revenue by type, collaboration and product (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Disclosure of disaggregation of revenue from contracts with customers [line items]        
Revenue $ 925 $ 779 $ 1,640 $ 1,382
J&J        
Disclosure of disaggregation of revenue from contracts with customers [line items]        
Revenue 656 554 1,137 915
Roche        
Disclosure of disaggregation of revenue from contracts with customers [line items]        
Revenue 21 23 46 49
Novartis        
Disclosure of disaggregation of revenue from contracts with customers [line items]        
Revenue 109 81 200 145
BioNTech        
Disclosure of disaggregation of revenue from contracts with customers [line items]        
Revenue 11 37 30 74
Pfizer        
Disclosure of disaggregation of revenue from contracts with customers [line items]        
Revenue 22 20 41 37
AbbVie        
Disclosure of disaggregation of revenue from contracts with customers [line items]        
Revenue 5 2 8 53
Other        
Disclosure of disaggregation of revenue from contracts with customers [line items]        
Revenue 0 0 2 0
DARZALEX        
Disclosure of disaggregation of revenue from contracts with customers [line items]        
Revenue 638 538 1,088 885
Kesimpta        
Disclosure of disaggregation of revenue from contracts with customers [line items]        
Revenue 108 80 198 144
TEPEZZA        
Disclosure of disaggregation of revenue from contracts with customers [line items]        
Revenue 20 23 45 49
Other        
Disclosure of disaggregation of revenue from contracts with customers [line items]        
Revenue 23 18 47 33
Royalties        
Disclosure of disaggregation of revenue from contracts with customers [line items]        
Revenue 789 659 1,378 1,111
Reimbursement revenue        
Disclosure of disaggregation of revenue from contracts with customers [line items]        
Revenue 13 42 36 82
Milestone revenue        
Disclosure of disaggregation of revenue from contracts with customers [line items]        
Revenue 1 0 13 50
Collaboration revenue        
Disclosure of disaggregation of revenue from contracts with customers [line items]        
Revenue 21 16 37 30
Net product sales        
Disclosure of disaggregation of revenue from contracts with customers [line items]        
Revenue 101 62 176 109
Excluding net product sales        
Disclosure of disaggregation of revenue from contracts with customers [line items]        
Revenue $ 824 $ 717 $ 1,464 $ 1,273